PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.330
0.00 (0.00%)
At close: Jul 18, 2025, 4:00 PM
1.300
-0.030 (-2.26%)
After-hours: Jul 18, 2025, 6:22 PM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $69.10 million as of July 18, 2025. Its market cap has decreased by -14.99% in one year.
Market Cap
69.10M
Enterprise Value
-95.62M
1-Year Change
-14.99%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $69.10M, a decrease of -95.72%. That is a compound annual growth rate of -48.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 69.10M | -11.57% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.63B |
| Johnson & Johnson | 392.14B |
| AbbVie | 338.09B |
| Novo Nordisk | 292.40B |
| UnitedHealth Group | 261.32B |
| Novartis AG | 227.25B |
| AstraZeneca | 214.46B |
| Abbott Laboratories | 209.67B |